Emerging research suggests that gut microbiota can significantly influence the efficacy of cancer treatments such as chemotherapy and immunotherapy. For instance, specific bacterial strains have been shown to enhance the effectiveness of immune checkpoint inhibitors, a type of cancer immunotherapy. On the other hand, an imbalance in gut microbiota can lead to resistance to these treatments.
